Purdue Pharma

Amid the ongoing opioid crisis, Purdue Pharma has proposed a new bankruptcy plan. The pharmaceutical giant is offering a settlement of at least $7.4 billion to address its role in the crisis. What Happened: On Tuesday, the OxyContin maker submitted a revised bankruptcy plan, offering a settlement...

The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain medication OxyContin accountable for their role in the opioid crisis. This increased settlement, announced...

Massachusetts Attorney General Andrea Joy Campbell made it clear that her office will make sure the Sackler family that owns Purdue Pharma will make reparations to families negatively affected by the opioid epidemic, following the Supreme Court‘s 5-4 decision on Thursday to dismiss the...

In a historic move, Publicis Groupe SA (OTC:PUBGY), a French advertising company, has agreed to a $350 million settlement over its alleged role in the opioid crisis. This marks the first time an advertising firm has been held accountable for its part in the epidemic. What Happened: Publicis, the...

The Supreme Court is set to examine Purdue Pharma's proposed restructuring, the opioid company that sought bankruptcy in 2019. This move may change a four-decade method for managing vast legal liabilities from large-scale lawsuits. The Supreme Court temporarily suspended a multi-...

The Supreme Court temporarily suspended a multi-billion-dollar bankruptcy agreement involving Purdue Pharma. This arrangement would insulate the company's Sackler family owners from civil lawsuits linked to the opioid epidemic. Furthermore, the Court announced it would examine a...

On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits related to the opioid crisis. The court also announced that it will hear a challenge to the settlement...

A federal appeals court in New York cleared the way for a bankruptcy deal for opioid manufacturer Purdue Pharma in a deal that will essentially protect the Sackler family from future lawsuits in exchange for a contribution of up to $6 billion. The Sacklers earned billions...

King’s College London is the latest UK institution to sever all ties with the billionaire Sackler family amid outrage over its role in the deadly opioid epidemic in the U.S. that, as of 2021, has claimed the lives of more than 106,000 people.  The move comes several...

A fictionalized retelling of events, Netflix (NASDAQ: NFLX) upcoming series "Painkiller" is a scripted limited series that explores some of the origins and aftermath of the opioid crisis in the United States which, as of November 2021, has resulted in 106,000...

The popular, if disturbing Hulu drama series, "Dopesick" starring Michael Keaton, Kaitlyn Dever, Rosario Dawson and Peter Sarsgaard tells the story of the devastating opioid crisis in the U.S. between 1996 and 2007, which series creator Danny Strong...

After two years of contentious bargaining, a U.S. bankruptcy court judge approved a controversial plan that will dissolve Purdue Pharma, the company that has been blamed for fueling the nation's deadly opioid crisis. The decision provides sweeping immunity and will shield members of the wealthy...

The 15 states that had opposed Purdue Pharma’s controversial bankruptcy plan finally landed on a deal that clears the way for a $4.5 billion settlement, reported various media outlets. As part of the deal, Purdue will release millions of documents that detail the company’s role in the...

The Past Week, In A Nutshell What Happened: Last week ended negative alongside mixed messaging on stimulus. Remember This: “Markets have come a long way since the March lows, but we believe there may be more room for stocks to run,” said Jeff Buchbinder, Equity Strategist for LPL...

McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AmerisourceBergen Corp. (NYSE: ABC) have reached 11th-hour settlements to avert opioid trials in Ohio, The Wall Street Journal reported.  Details were expected to emerge early...